Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease
The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a ...
The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a ...
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought ...
An experimental gene therapy from Sarepta Therapeutics increased levels of the gene missing in an ultra-rare form of muscular dystrophy, ...
In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory ...
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Kent Kanouse / Flickr cc People who live with or handle pet bearded dragons are at continued risk for Salmonella ...
Tumors caused by recurrent respiratory papillomatosis are benign, but that doesn’t mean they are not serious. In this rare disease, ...
As with most rare diseases, the market for hereditary angioedema drugs is small. It’s also relatively crowded, served by several ...
Capricor Therapeutics’ cell therapy for Duchenne muscular dystrophy has come up short at the FDA, with the regulator rejecting the ...
Patients with tenosynovial giant cell tumor can take some comfort in knowing that this rare type of tumor affecting joints ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.